{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:16:15Z","timestamp":1793880975060,"version":"4.7.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["250219"],"award-info":[{"award-number":["250219"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"JSPS","doi-asserted-by":"publisher","award":["26461015"],"award-info":[{"award-number":["26461015"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-AI-020001"],"award-info":[{"award-number":["R01-AI-020001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-CA-040489"],"award-info":[{"award-number":["R01-CA-040489"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.coi.2015.06.016","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T22:15:41Z","timestamp":1436912141000},"page":"61-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"special_numbering":"C","title":["Host\u2013virus interactions in hepatitis B virus infection"],"prefix":"10.1016","volume":"36","author":[{"given":"Luca G","family":"Guidotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Isogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis V","family":"Chisari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2015.06.016_sbref0005","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480C","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.coi.2015.06.016_bib0010","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2015.06.016_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","article-title":"Hepatitis B virus immunopathogenesis","volume":"13","author":"Chisari","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2015.06.016_bib0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.pathol.1.110304.100230","article-title":"Immunobiology and pathogenesis of viral hepatitis","volume":"1","author":"Guidotti","year":"2006","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.coi.2015.06.016_bib0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)80295-2","article-title":"Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes","volume":"4","author":"Guidotti","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2015.06.016_bib0030","doi-asserted-by":"crossref","first-page":"e1003730","DOI":"10.1371\/journal.pcbi.1003730","article-title":"Antibody responses during hepatitis B viral infection","volume":"10","author":"Ciupe","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.coi.2015.06.016_bib0035","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1002\/hep.22962","article-title":"Hepatitis B and hepatocellular carcinoma","volume":"49","author":"Di Bisceglie","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.coi.2015.06.016_bib0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1086\/653622","article-title":"The prevalence of hepatitis B virus infection in the United States in the era of vaccination","volume":"202","author":"Wasley","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2015.06.016_bib0045","doi-asserted-by":"crossref","first-page":"a024935","DOI":"10.1101\/cshperspect.a024935","article-title":"Viral hepatitis B: clinical and epidemiological characteristics","volume":"4","author":"Burns","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.coi.2015.06.016_bib0050","first-page":"5","article-title":"Antiviral therapies and prospects for a cure of chronic hepatitis B","author":"Zoulim","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.coi.2015.06.016_bib0055","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.07.014","article-title":"Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues","volume":"143","author":"Boni","year":"2012","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"10.1016\/j.coi.2015.06.016_sbref0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/liv.12749","article-title":"HBV and the immune response","volume":"35","author":"Ferrari","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.coi.2015.06.016_bib0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2015.06.016_sbref0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.immuni.2014.12.016","article-title":"The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus","volume":"42","author":"Sato","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2015.06.016_bib0075","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-7613(02)00305-9","article-title":"Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection","volume":"16","author":"Baron","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2015.06.016_bib0080","doi-asserted-by":"crossref","first-page":"18187","DOI":"10.1073\/pnas.0708968104","article-title":"Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus","volume":"104","author":"Vilarinho","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2015.06.016_bib0085","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm.2811","article-title":"Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity","volume":"18","author":"Zeissig","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2015.06.016_bib0090","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/JVI.76.6.2617-2621.2002","article-title":"Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice","volume":"76","author":"Guidotti","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2015.06.016_bib0095","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1128\/JVI.74.5.2255-2264.2000","article-title":"Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines","volume":"74","author":"McClary","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2015.06.016_bib0100","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1128\/JVI.74.9.4165-4173.2000","article-title":"Intrahepatic induction of alpha\/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice","volume":"74","author":"Wieland","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2015.06.016_bib0105","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1128\/JVI.79.6.3851-3854.2005","article-title":"Lambda interferon inhibits hepatitis B and C virus replication","volume":"79","author":"Robek","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2015.06.016_bib0110","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.192.7.921","article-title":"Natural killer T cell activation inhibits hepatitis B virus replication in vivo","volume":"192","author":"Kakimi","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2015.06.016_bib0115","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.4049\/jimmunol.169.9.5188","article-title":"Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice","volume":"169","author":"Kimura","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2015.06.016_bib0120","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1128\/JVI.79.11.7269-7272.2005","article-title":"Toll-like receptor signaling inhibits hepatitis B virus replication in vivo","volume":"79","author":"Isogawa","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2015.06.016_sbref0125","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1053\/j.gastro.2013.02.003","article-title":"GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees","volume":"144","author":"Lanford","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coi.2015.06.016_bib0130","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(76)90598-5","article-title":"Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer","volume":"2","author":"Purcell","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2015.06.016_bib0135","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1189\/JLB.0309135","article-title":"Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases","volume":"86","author":"Gao","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.coi.2015.06.016_bib0140","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.4049\/jimmunol.1203218","article-title":"IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells","volume":"190","author":"Tang","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2015.06.016_bib0145","doi-asserted-by":"crossref","first-page":"e1004210","DOI":"10.1371\/journal.ppat.1004210","article-title":"Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver","volume":"10","author":"Jo","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2015.06.016_sbref0150","doi-asserted-by":"crossref","first-page":"e1003208","DOI":"10.1371\/journal.ppat.1003208","article-title":"The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells","volume":"9","author":"Schurich","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2015.06.016_bib0155","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20061287","article-title":"Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage","volume":"204","author":"Dunn","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2015.06.016_sbref0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20121172","article-title":"Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion","volume":"210","author":"Peppa","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2015.06.016_bib0165","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ni.2573","article-title":"Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection","volume":"14","author":"Huang","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2015.06.016_bib0170","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1128\/JVI.79.5.3016-3027.2005","article-title":"Immune tolerance split between hepatitis B virus precore and core proteins","volume":"79","author":"Chen","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2015.06.016_bib0175","doi-asserted-by":"crossref","first-page":"14913","DOI":"10.1073\/pnas.0406282101","article-title":"A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen","volume":"101","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2015.06.016_bib0180","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1084\/jem.20011723","article-title":"Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection","volume":"195","author":"Reignat","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2015.06.016_bib0185","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/369407a0","article-title":"Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells","volume":"369","author":"Bertoletti","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.coi.2015.06.016_bib0190","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1172\/JCI118191","article-title":"Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection","volume":"96","author":"Rehermann","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2015.06.016_sbref0195","doi-asserted-by":"crossref","first-page":"e1003490","DOI":"10.1371\/journal.ppat.1003490","article-title":"CD40 activation rescues antiviral CD8(+) T cells from PD-1-mediated exhaustion","volume":"9","author":"Isogawa","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2015.06.016_sbref0200","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1172\/JCI68182","article-title":"Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B","volume":"123","author":"Publicover","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2015.06.016_bib0205","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.celrep.2013.02.008","article-title":"Liver-primed memory T cells generated under noninflammatory conditions provide anti-infectious immunity","volume":"3","author":"Bottcher","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2015.06.016_bib0210","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.24249","article-title":"Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection","volume":"53","author":"Schurich","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.coi.2015.06.016_bib0215","doi-asserted-by":"crossref","first-page":"e47648","DOI":"10.1371\/journal.pone.0047648","article-title":"Upregulation of the Tim-3\/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection","volume":"7","author":"Nebbia","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2015.06.016_bib0220","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.3748\/wjg.v13.i36.4858","article-title":"Regulatory T cells in viral hepatitis","volume":"13","author":"Billerbeck","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coi.2015.06.016_sbref0225","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nm.3856","article-title":"Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells","volume":"21","author":"Pallett","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2015.06.016_bib0230","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.4049\/jimmunol.1103139","article-title":"IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection","volume":"189","author":"Das","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2015.06.016_sbref0235","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.cell.2015.03.005","article-title":"Immunosurveillance of the liver by intravascular effector CD8(+) T cells","volume":"161","author":"Guidotti","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.coi.2015.06.016_bib0240","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1152\/physrev.00027.2008","article-title":"The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair","volume":"89","author":"Vollmar","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.coi.2015.06.016_bib0245","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2013.04.047","article-title":"T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice","volume":"145","author":"Krebs","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coi.2015.06.016_bib0250","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jhep.2010.10.025","article-title":"Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines","volume":"55","author":"Gehring","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.coi.2015.06.016_sbref0255","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2014.10.001","article-title":"Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient","volume":"62","author":"Qasim","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.coi.2015.06.016_bib0260","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1084\/jem.188.2.341","article-title":"Immune pathogenesis of hepatocellular carcinoma","volume":"188","author":"Nakamoto","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2015.06.016_bib0265","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1158\/0008-5472.CAN-03-3817","article-title":"Different procarcinogenic potentials of lymphocyte subsets in a transgenic mouse model of chronic hepatitis B","volume":"64","author":"Nakamoto","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.coi.2015.06.016_bib0270","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1317","article-title":"Platelets mediate cytotoxic T lymphocyte-induced liver damage","volume":"11","author":"Iannacone","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2015.06.016_bib0275","doi-asserted-by":"crossref","first-page":"E2165","DOI":"10.1073\/pnas.1209182109","article-title":"Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B","volume":"109","author":"Sitia","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2015.06.016_bib0280","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.coi.2015.06.016_bib0285","doi-asserted-by":"crossref","first-page":"9652","DOI":"10.1128\/JVI.00867-09","article-title":"The size of the viral inoculum contributes to the outcome of hepatitis B virus infection","volume":"83","author":"Asabe","year":"2009","journal-title":"J Virol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791515000977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791515000977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:38:19Z","timestamp":1760603899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791515000977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":57,"alternative-id":["S0952791515000977"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2015.06.016","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host\u2013virus interactions in hepatitis B virus infection","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2015.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}